Leveraging Next-Generation Protein Sequencing in the CRO Setting

This case study discusses the integration of Quantum-Si’s Platinum Next-Generation Protein Sequencer into Gipfel Life Sciences, a contract research organization (CRO) focused on the biopharmaceutical industry. The CEO, Ozan Fidan, outlines how the technology enhances capabilities in various applications, including biomarker identification and assessments of in vivo stability for recombinant antibodies. The study highlights the emerging field of allergo-oncology, which examines the relationship between allergies and cancer, and how the sequencer may contribute to this research. Additionally, it details plans for immunopeptidomics studies aimed at identifying peptides presented by MHC molecules, which are crucial for immune responses. The case study also mentions the user-friendly nature of the Platinum instrument and its cloud-based technology, which allows for remote data access. Furthermore, it emphasizes the support provided by Quantum-Si’s technical teams in helping Gipfel expand its services.